Risk assessment and management of cerebral aneurysms (legacy)

Description: The second generation demonstrator created for the @neurIST project

Publet Introduction:

This publet illustrates the potential for decision support within Clinical Evidence: support is provided for the question “Which treatments improve outcomes in cerebral aneurysms?”

 Information
Guideline Objectives

To provide recommendation for the patients with cecebral @neurissms for the decision “To treat or to survay” based on the evidence collected or delivered by the @neuriST project

Target SettingSecondary Care
Target Users
  • Author
  • Release Date
Overview
  • 3DRA Imaging
  • Gene Expression Profile
  • Neurosurgical Clipping
  • Endovascular Coiling
  • Endovascular Stenting
Provenance
Management

To provide recommendation for the patients with cecebral @neurissms for the decision “To treat or to survay” based on the evidence collected or delivered by the @neuriST project

Safety Case@neurist Use case
Sources
  • M. Clarcke. @neurIST Deliverable 18: Cochrane Literature Review Snapshot v2.0 – Aneurysm analysis rupture risk review.
  • O. Wiebers. Unruptured intracranial aneurysms: natural history, clinicaloutcome, and risks of surgical and endovascular treatment. THE LANCET • Vol 362 • July 12, 200
  • R R Vindlacheruvu, A D Mendelow, P Mitchell. Risk–benefit analysis of the treatment of unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2005;76:234–239
  • P. Mitchell and J. Jakubowski. Risk analysis of treatment of unruptured aneurysms. J. Neurol. Neurosurg. Psychiatry 200
References